These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1516 related items for PubMed ID: 27454870

  • 1. Impact of Fluorine-18 2-Fluoro-2-Deoxy-D-Glucose Uptake on Preoperative Positron Emission Tomography/Computed Tomography in the Lymph Nodes of Patients with Primary Colorectal Cancer.
    Sasaki K, Kawasaki H, Sato M, Koyama K, Yoshimi F, Nagai H.
    Dig Surg; 2017; 34(1):60-67. PubMed ID: 27454870
    [Abstract] [Full Text] [Related]

  • 2. Pelvic Lymph Node Staging by Combined 18F-FDG-PET/CT Imaging in Bladder Cancer Prior to Radical Cystectomy.
    Pichler R, De Zordo T, Fritz J, Kroiss A, Aigner F, Heidegger I, Virgolini I, Horninger W, Uprimny C.
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [Abstract] [Full Text] [Related]

  • 3. Can 3'-Deoxy-3'-((18)F) Fluorothymidine Out Perform 2-Deoxy-2-((18)F) Fluoro-D-Glucose Positron Emission Tomography/Computed Tomography in the Diagnosis of Cervical Lymphadenopathy in Patients With Oral/Head and Neck Cancer?
    Schaefferkoetter JD, Carlson ER, Heidel RE.
    J Oral Maxillofac Surg; 2015 Jul; 73(7):1420-8. PubMed ID: 25869746
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.
    Swinnen G, Maes A, Pottel H, Vanneste A, Billiet I, Lesage K, Werbrouck P.
    Eur Urol; 2010 Apr; 57(4):641-7. PubMed ID: 19477579
    [Abstract] [Full Text] [Related]

  • 7. Elevated tumor-to-liver uptake ratio (TLR) from 18F-FDG-PET/CT predicts poor prognosis in stage IIA colorectal cancer following curative resection.
    Huang J, Huang L, Zhou J, Duan Y, Zhang Z, Wang X, Huang P, Tan S, Hu P, Wang J, Huang M.
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [Abstract] [Full Text] [Related]

  • 8. Diagnostic accuracy of 18F-2-deoxy-fluoro-D-glucose positron emission tomography for pN1 lymph nodes in patients with lung cancer.
    Nakagawa M, Hara M, Sakurai K, Ozawa Y, Mizuno A, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2009 Jul; 50(6):638-44. PubMed ID: 19492198
    [Abstract] [Full Text] [Related]

  • 9. The diagnostic ability of 18F-FDG PET/CT for mediastinal lymph node staging using 18F-FDG uptake and volumetric CT histogram analysis in non-small cell lung cancer.
    Lee JW, Kim EY, Kim DJ, Lee JH, Kang WJ, Lee JD, Yun M.
    Eur Radiol; 2016 Dec; 26(12):4515-4523. PubMed ID: 26943133
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic accuracy of (18)F-2-deoxy-fluoro-D-glucose positron emission tomography for pN2 lymph nodes in patients with lung cancer.
    Ozawa Y, Hara M, Sakurai K, Nakagawa M, Tamaki T, Nishio M, Shibamoto Y.
    Acta Radiol; 2010 Mar; 51(2):150-5. PubMed ID: 20092375
    [Abstract] [Full Text] [Related]

  • 11. Accuracy of F-18 FDG PET/CT with optimal cut-offs of maximum standardized uptake value according to size for diagnosis of regional lymph node metastasis in patients with rectal cancer.
    Bae SU, Won KS, Song BI, Jeong WK, Baek SK, Kim HW.
    Cancer Imaging; 2018 Sep 14; 18(1):32. PubMed ID: 30217167
    [Abstract] [Full Text] [Related]

  • 12. Clinical impact of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in patients with resectable pancreatic cancer: diagnosing lymph node metastasis and predicting survival.
    Kim HR, Seo M, Nah YW, Park HW, Park SH.
    Nucl Med Commun; 2018 Jul 14; 39(7):691-698. PubMed ID: 29893751
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The role of (18)F-FDG PET/CT in the diagnosis of breast cancer and lymph nodes metastases and micrometastases may be limited.
    Zhang X, Wu F, Han P.
    Hell J Nucl Med; 2014 Jul 14; 17(3):177-83. PubMed ID: 25526754
    [Abstract] [Full Text] [Related]

  • 15. Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
    Kawashima K, Kato K, Tomabechi M, Matsuo M, Otsuka K, Ishida K, Nakamura R, Ehara S.
    Br J Radiol; 2016 Jul 14; 89(1063):20150938. PubMed ID: 27146065
    [Abstract] [Full Text] [Related]

  • 16. Preoperative lymph-node staging of invasive urothelial bladder cancer with 18F-fluorodeoxyglucose positron emission tomography/computed axial tomography and magnetic resonance imaging: correlation with histopathology.
    Jensen TK, Holt P, Gerke O, Riehmann M, Svolgaard B, Marcussen N, Bouchelouche K.
    Scand J Urol Nephrol; 2011 Mar 14; 45(2):122-8. PubMed ID: 21231796
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography with Computed Tomography for Lymph Node Staging in Patients with Upper Tract Urothelial Carcinoma.
    Voskuilen CS, Schweitzer D, Jensen JB, Nielsen AM, Joniau S, Muilwijk T, Necchi A, Azizi M, Spiess PE, Briganti A, Bandini M, Goffin K, Bouchelouche K, van Werkhoven E, Shariat SF, Xylinas E, Azawi NH, Ku JH, Foerster B, van Rhijn BWG, Vegt E, Hendricksen K.
    Eur Urol Oncol; 2020 Feb 14; 3(1):73-79. PubMed ID: 31591037
    [Abstract] [Full Text] [Related]

  • 18. Diagnostic value of FDG-PET/CT for lymph node metastasis of colorectal cancer.
    Kwak JY, Kim JS, Kim HJ, Ha HK, Yu CS, Kim JC.
    World J Surg; 2012 Aug 14; 36(8):1898-905. PubMed ID: 22526032
    [Abstract] [Full Text] [Related]

  • 19. Lymph node metastasis diagnosis using positron emission tomography with 2-[18F] fluoro-2-deoxy-D-glucose as a tracer and computed tomography in surgical cases of non-small cell lung cancer.
    Ose N, Sawabata N, Minami M, Inoue M, Shintani Y, Kadota Y, Okumura M.
    Eur J Cardiothorac Surg; 2012 Jul 14; 42(1):89-92. PubMed ID: 22290887
    [Abstract] [Full Text] [Related]

  • 20. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
    Caobelli F, Alongi P, Evangelista L, Picchio M, Saladini G, Rensi M, Geatti O, Castello A, Laghai I, Popescu CE, Dolci C, Crivellaro C, Seghezzi S, Kirienko M, De Biasi V, Cocciolillo F, Quartuccio N, Young AIMN Working Group.
    Eur J Nucl Med Mol Imaging; 2016 Mar 14; 43(3):404-13. PubMed ID: 26381775
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 76.